Literature DB >> 17144600

Unusually high serum levels of lactate dehydrogenase without perivalvular leakage following double valve replacement: predictor of tetany attack after thyroidectomy.

Masaaki Ryomoto1, Yuji Miyamoto, Masataka Mitsuno, Mitsuhiro Yamamura, Toshihiro Ohata, Hiroe Tanaka.   

Abstract

A 57-year-old woman who complained of exertional dyspnea was diagnosed as having severe aortic valve stenosis and mitral valve regurgitation. The patient underwent double valve replacement with a mechanical prosthesis. Postoperative laboratory data showed unusually high serum lactate dehydrogenase (LDH) levels, even though no perivalvular leakage was detected by echocardiography. Tetany occurred suddenly owing to hypoparathyroidism, which seemed to be a late complication after thyroidectomy. After calcium administration, the symptoms dramatically diminished, as did the serum LDH levels. Hypoparathyroidism should be doubted if serum LDH levels increase higher than the normal range following valve replacement without obvious perivalvular leakage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17144600     DOI: 10.1007/s11748-006-0040-3

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  3 in total

1.  Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study.

Authors:  Gianclaudio Mecozzi; Aldo D Milano; Marco De Carlo; Flavia Sorrentino; Stefano Pratali; Carmela Nardi; Uberto Bortolotti
Journal:  J Thorac Cardiovasc Surg       Date:  2002-03       Impact factor: 5.209

2.  Morbidity of thyroid surgery.

Authors:  R Bergamaschi; G Becouarn; J Ronceray; J P Arnaud
Journal:  Am J Surg       Date:  1998-07       Impact factor: 2.565

3.  Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years.

Authors:  Lodovico Rosato; Nicola Avenia; Paolo Bernante; Maurizio De Palma; Giuseppe Gulino; Pier Giorgio Nasi; Maria Rosa Pelizzo; Luciano Pezzullo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.